Summary of AVEO PHARMACEUTICALS INC

Item 5.07 Submission of Matters to a Vote of Security Holders.

At the annual meeting of shareholders of AVEO Pharmaceuticals, Inc. (the "Company") held on May 30, 2012, the Company's shareholders voted on the following proposals:

1. The following nominees were elected to the Company's Board of Directors for terms expiring at the 2013 annual meeting of shareholders.

                                   For            Withheld        Broker Non-Votes
       Mr. Kenneth Bate          33,585,100          150,035              4,356,839
       Dr. Ronald DePinho        33,623,051          112,084              4,356,839
       Dr. Anthony Evnin         33,708,223           26,912              4,356,839
       Mr. Tuan Ha-Ngoc          33,670,381           64,754              4,356,839
       Dr. Raju Kucherlapati     33,662,626           72,509              4,356,839
       Mr. Henri Termeer         33,579,070          156,065              4,356,839
       Mr. Kenneth Weg           19,084,041       14,651,094              4,356,839
       Dr. Robert Young          33,707,123           28,012              4,356,839

2. A non-binding, advisory proposal on the compensation of the Company's named executive officers was approved.

                         For:                  33,471,047
                         Against:                 256,138
                         Abstain:                   7,950
                         Broker Non-Votes:      4,356,839

3. The appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2012 was ratified.

                             For:         37,919,378
                             Against:        160,724
                             Abstain:         11,872